Immunosuppressant switch cuts skin cancer post-transplant – medicalxpress.com

(HealthDay) — In kidney-transplant patients with at least one cutaneous squamous-cell carcinoma, switching immunosuppressants (from calcineurin inhibitors to sirolimus) is associated with increased skin cancer-free survival and delayed …